{
    "2020-08-12": [
        [
            {
                "time": "",
                "original_text": "世界500强企业：中国有134家，美国121家，为何俄罗斯只有4家呢？",
                "features": {
                    "keywords": [
                        "世界500强",
                        "中国",
                        "美国",
                        "俄罗斯"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "经济",
                        "国际比较"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "第三批国采，这些药企有机会（附名单）",
                "features": {
                    "keywords": [
                        "国采",
                        "药企",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒指收涨1.42% 水务板块领涨",
                "features": {
                    "keywords": [
                        "恒指",
                        "收涨",
                        "水务板块",
                        "领涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "水务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "交银：看好具备强大创新管线的制药公司 推荐中生制药",
                "features": {
                    "keywords": [
                        "交银",
                        "创新管线",
                        "制药公司",
                        "中生制药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国投瑞银创新医疗混合基金最新净值跌幅达2.33％",
                "features": {
                    "keywords": [
                        "国投瑞银",
                        "创新医疗",
                        "混合基金",
                        "净值跌幅"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药领域出现新研发热点，大批药企斥巨资布局",
                "features": {
                    "keywords": [
                        "医药领域",
                        "研发热点",
                        "药企",
                        "巨资布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安进抢占先机 强生、辉瑞等MNC巨额布局 这一领域热点在哪里？",
                "features": {
                    "keywords": [
                        "安进",
                        "强生",
                        "辉瑞",
                        "MNC",
                        "巨额布局",
                        "领域热点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}